Definitive Healthcare Corp. (DH)

Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Jonathan Paris - Chief Legal Officer & Secretary Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Nishad Patwardhan - Goldman Sachs Group, Inc., Research Division Johnathan McCary - Raymond James & Associates, Inc., Research Division Jenny Shen - BTIG, LLC, Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Welcome to Definitive Healthcare's Q3 2025 Earnings Call.

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.1 per share a year ago.

FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025.

FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an industry where legacy agencies struggle to scale, Salubrum's AI-first approach productizes and automates the traditional marketing agency. Salubrum has partnered with industry giant Definitive Healthcare (NASDAQ: DH) to provide best-in-class precision patient activation, reimagining how healthcare brands go to market.

Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Definitive Healthcare Corp. (NASDAQ:DH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. Great. Well, good morning, everyone.

FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief Financial Officer, Casey Heller, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference.

Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and BlackLine (BL). But which of these two stocks offers value investors a better bang for their buck right now?

Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Casey Heller - Chief Financial Officer Jonathan Paris - Chief Legal Officer Kevin D. Coop - CEO & Director Conference Call Participants David Michael Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division George Robert Hill - Deutsche Bank AG, Research Division Johnathan M.

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.09 per share a year ago.

FRAMINGHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025 after market close.

FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeannine Lombardi, Definitive Healthcare's new Chief Human Resource Officer, an inducement award consisting of 421,349 time-based restricted stock units (“RSUs”), and Jonathan Paris, Definitive Healthcare's new Chief Legal Officer, an inducement award consisting of 421,349 time-based RSUs, each effective July 1, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Lombardi's and Mr. Paris's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted an inducement award.

Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - CEO Rick Booth - CFO Casey Heller - SVP, Finance Conference Call Participants Jared Haase - William Blair Craig Hettenbach - Morgan Stanley David Grossman - Stifel George Hill - Deutsche Bank Jenny Shen - BTIG Operator Welcome to Definitive Healthcare's Q1 2025 Earnings Call. Later, we will conduct a question and answer session.

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.08 per share a year ago.